Airbnb Inc
$ 136.62
-0.15%
29 Dec - close price
- Market Cap 83,766,084,000 USD
- Current Price $ 136.62
- High / Low $ 137.16 / 136.16
- Stock P/E 32.58
- Book Value 14.16
- EPS 4.20
- Next Earning Report 2026-02-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.31 %
- 52 Week High 163.93
- 52 Week Low 99.88
About
Airbnb, Inc. (ABNB) is a pioneering online marketplace that has transformed the travel and hospitality sector since its founding in 2008 in San Francisco, California. By connecting travelers with a vast array of unique accommodations and authentic local experiences, Airbnb enriches consumer journeys, catering to the growing demand for distinctive travel options in a post-pandemic world. The company's innovative technology and strong commitment to community engagement enable it to adapt to evolving consumer preferences effectively. With a robust global footprint and a focus on enhancing interactions between guests and hosts, Airbnb is well-positioned to maintain its influential role in the reimagined tourism market.
Analyst Target Price
$140.23
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-06 | 2025-05-01 | 2025-02-13 | 2024-11-07 | 2024-08-06 | 2024-05-08 | 2024-02-13 | 2023-11-01 | 2023-08-03 | 2023-05-09 | 2023-02-14 |
| Reported EPS | 2.21 | 1.03 | 0.24 | 0.73 | 2.13 | 0.86 | 0.41 | 0.76 | 6.63 | 0.98 | 0.18 | 0.48 |
| Estimated EPS | 2.32 | 0.94 | 0.24 | 0.58 | 2.13 | 0.91 | 0.23 | 0.62 | 2.15 | 0.78 | 0.1 | 0.33 |
| Surprise | -0.11 | 0.09 | 0 | 0.15 | 0 | -0.05 | 0.18 | 0.14 | 4.48 | 0.2 | 0.08 | 0.15 |
| Surprise Percentage | -4.7414% | 9.5745% | 0% | 25.8621% | 0% | -5.4945% | 78.2609% | 22.5806% | 208.3721% | 25.641% | 80% | 45.4545% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-12 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.66 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ABNB
2025-12-30 03:16:09
Booking Holdings (BKNG) shares closed nearly flat, influenced by late-December fund flows and thin liquidity, despite a $260 million weekly outflow from an ETF holding Booking. Investors are observing a Dec. 31 cash dividend and an estimated Feb. 19 earnings report. Analysts remain optimistic about resilient demand in online travel.
2025-12-24 20:09:12
The Bitwise MSTR Option Income Strategy ETF (NYSEARCA: ABNB) has declared a monthly dividend of $1.308 per share. This dividend is payable on January 2, 2025, to shareholders of record as of December 26, 2024, with an ex-dividend date of December 26, 2024.
2025-12-24 05:09:51
LogProstyle Inc. reported its fiscal results for the first half of FY2026, showcasing strong growth in its hospitality division despite a modest overall revenue decline. The company's hotel revenue increased by 10.7%, driven by higher occupancy rates and average daily rates, fueled by Japan's booming inbound tourism. LogProstyle is expanding its hotel portfolio, with a new property in Tokyo's Asakusa district slated to open in 2028, underscoring its commitment to sustainable growth in the Japanese tourism market.
2025-12-24 02:51:29
Booking Holdings (BKNG) is re-evaluating its valuation after increasing its cost-saving target to $550 million, partnering with viagogo, and facing a new legal challenge from a Berlin court. Despite these factors, the stock shows strong momentum with significant share price returns over the past three years. The narrative suggests BKNG is currently 12.4% undervalued, driven by AI integration, alternative accommodations, and loyalty program expansion, although geopolitical uncertainty and rising customer acquisition costs pose potential risks.
2025-12-23 15:08:15
SKYX Platforms Corp. (NASDAQ:SKYX) has seen a significant 33% price gain in the last month, contributing to a 138% increase over the past year. Despite its 3x price-to-sales (P/S) ratio in an industry where nearly half of companies are below 2.3x, analysts forecast strong revenue growth of 26% per annum over the next three years, exceeding the industry average of 16%. This strong outlook on future revenues appears to be supporting its high P/S ratio.
2025-12-23 06:32:59
Ocugen's CEO recently presented at a rare disease summit, focusing on the company's gene and cell therapy pipeline, which could influence its investment narrative and risk profile. This appearance, alongside a recent licensing agreement for OCU400, underscores Ocugen's ambitions in rare disease gene therapies, yet the company still faces funding challenges and clinical trial risks. The article also touches on Ocugen's revenue and earnings forecasts, limited cash runway, and a wide range of fair value estimates from the Simply Wall St Community.
